Studies Health Outcomes and Causes of Uterine Birth Differences
Observes women with uterine differences present from birth, examining cancer links and possible causes.
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Registry title
- Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 14 Jul 2021
- Expected to end
- Aug 2027
- Type of study
- Observational
- Record updated
- 9 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for females aged 13 or older who have a congenital uterine anomaly, a difference in the shape of the uterus present from birth. It studies health outcomes, cancer links, and genetic and environmental causes.
- Age
- 13 years or older
- Sex
- Females only
- Disease stage
- A diagnosis of any variation of congenital uterine anomaly (CUA).
Main reasons for not taking part
- Declines to take part when contacted
- Non-English speaking, except Spanish speaking
- Unable to take part in the consent or assent process due to mental disability
- Care not received at Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital or Lawrence+ Memorial Hospital
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- females
- age: 13 or older
- encounters limited to: Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital and Lawrence+ Memorial Hospital
- diagnosis of any variation of CUA
Who cannot take part
- who will decline to participate in a study upon contact
- non-English speaking except Spanish speaking
- unable to participate in consent or assent process due to mental disability
This trial is currently available in United States.
- Yale UniversityNew Haven, United StatesContact: Monica G Konstantino, RNTaking people
About the trial
What the trial wants to find out
The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vaginal and uterine cancers) exist in females with CUAs. The investigator will also investigate any environmental and genetic factors that may be responsible for causing CUAs.
The group in the trial
- Patients with Congenital Uterine Anomalies (CUA)
The rates of renal, breast, uterine, ovarian and vaginal cancers in women who have been diagnosed with a CUA will be studies
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
- Plain-language title
- Studies Health Outcomes and Causes of Uterine Birth DifferencesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 June 2026